Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Specimen Handling 38Magnetic Resonance Spectroscopy 34Radiation 15Biopsy 15Radiotherapy 14Cyclophosphamide 13Vincristine 11Dexamethasone 11Cisplatin 10Carboplatin 10Leucovorin 9X-Rays 8Fluorouracil 8Etoposide 8Calcium Dobesilate 8dexamethasone acetate 7dexamethasone 21-phosphate 7auricularum 7Standard of Care 7Practice Guidelines as Topic 7Platinum 7Doxorubicin 7Cytarabine 71,2-diaminocyclohexaneplatinum II citrate 7dehydroftorafur 6daratumumab 6Taxes 6Radiotherapy, Intensity-Modulated 6Observation 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × BCG Vaccine × 30 days × Clear all
NCT05538663 2026-05-05

BRIDGE

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
870 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡